Table 1. Clinical characteristics of Crohn’s disease patients.
CRP (mgr/L) | CDAI | Sema3A expression on CD4 + CD25 + (%) | Gender | Age (Yr) | Patient Num. |
---|---|---|---|---|---|
Active Crohn’s | |||||
80.7 | 252 | 66.3% | Female | 40 | 1 |
14 | 222 | 65.9% | Male | 28 | 2 |
222.3 | 358 | 74.5% | Male | 26 | 3 |
249.3 | 328 | 73.6% | Female | 46 | 4 |
33.4 | 215 | 64.1% | Female | 55 | 5 |
123.4 | 339 | 75% | Female | 21 | 6 |
17 | 220 | 59% | Female | 23 | 7 |
13.4 | 244 | 78.2% | Male | 22 | 8 |
208.6 | 389 | 69% | Male | 24 | 9 |
73.8 | 302 | 68% | Male | 70 | 10 |
102.3 | 292 | 74% | Female | 38 | 11 |
219.7 | 324 | 52.2% | Male | 36 | 12 |
61 | 289 | 63.8% | Female | 69 | 13 |
81.6 | 301 | 57.1% | Male | 27 | 14 |
19 | 267 | 74% | Female | 40 | 15 |
Silent Crohn’s | |||||
1 | 66 | 86.7% | Female | 62 | 16 |
3.6 | 41 | 84.6% | Female | 44 | 17 |
5.8 | 32 | 90.4% | Male | 52 | 18 |
1.2 | 35 | 87% | Male | 30 | 19 |
16.9 | 80 | 79% | Male | 28 | 20 |
14.7 | 110 | 82% | Male | 29 | 21 |
4.5 | 56 | 78.2% | Female | 59 | 22 |
2.9 | 44 | 77.1% | Female | 47 | 23 |
0.7 | 59 | 59.1% | Female | 40 | 24 |
3.4 | 41 | 64.2% | Female | 62 | 25 |
8 | 69 | 65.1% | Female | 55 | 26 |
0.8 | 38 | 77.7% | Female | 33 | 27 |